Estrogen to treat Alzheimer’s disease: Too little, too late?: So what’s a woman to do?
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Estrogen was the hormone of the 1990s, empowering postmenopausal women against the future ravages of osteoporosis, cardiovascular disease, and perhaps AD. Three large primary prevention trials in AD will provide information in several years on the efficacy of estrogen replacement therapy (ERT) in preventing or delaying the onset of AD. In this issue of Neurology , Wang et al.1 present the third large double-blind, placebo-controlled trial of estrogen in women with AD published this year. All three studies1-3 found no role for conjugated equine estrogens (CEE) in the treatment of postmenopausal women with AD (table). View this table: Table 1. Characteristics of the studies Laboratory evidence suggests that estrogen may increase cholinergic transmission, has neurotrophic effects,4 and has antiamyloidogenic properties.5 This has made estrogen an attractive candidate for both prevention and treatment of AD. A meta-analysis of 10 studies, including …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of estrogen in young girls with Turner syndrome: Effects on memory
Ross, J. L., Roeltgen, D., Feuillan, P., Kushner, H., & Cutler, G. B. (2000) · Neurology · doi:10.1212/wnl.54.1.164 · Cited by 123
Height, Bone Mineral Density and Bone Markers in Congenital Adrenal Hyperplasia
Paganini, C., Radetti, G., Livieri, C., Braga, V., Migliavacca, D., & Adami, S. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053253 · Cited by 87
Cited by
The 2017 hormone therapy position statement of The North American Menopause Society
(2017) · Menopause · doi:10.1097/gme.0000000000000921 · Cited by 1,001
The 2022 hormone therapy position statement of The North American Menopause Society
(2022) · Menopause · doi:10.1097/gme.0000000000002028 · Cited by 977
Zandi, P. P. (2002) · JAMA · doi:10.1001/jama.288.17.2123 · Cited by 906
Understanding the impact of sex and gender in Alzheimer’s disease: A call to action
Nebel, R. A., Aggarwal, N. T., Barnes, L. L., Gallagher, A., Goldstein, J. M., Kantarci, K., Mallampalli, M. P., Mormino, E. C., Scott, L., Yu, W. H., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.04.008 · Cited by 839
“hypothesis of HT, which suggests that early initiation of HT in relation to the menopausal transition confers greater cognitive benefit than initiation later in life [76,77].”
BackgroundEstrogen and cognitive functioning in women
Sherwin, B. B. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0016 · Cited by 560
Metadata
- Authors
- Marder, K., & Sano, M.
- Venue
- Neurology
- Published
- 2000-06-13
- Volume
- 54
- Issue
- 11
- Pages
- 2035-2037
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2122890373
- Cited by
- 75
- References
- 2
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estrogen to treat Alzheimer’s disease: Too little, too late?: So what’s a woman to do? https://app.cochat.ai/papers/10.1212/wnl.54.11.2035
- The paper
- Marder, K., & Sano, M. (2000). Estrogen to treat Alzheimer’s disease: Too little, too late?: So what’s a woman to do? Neurology. https://doi.org/10.1212/wnl.54.11.2035
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.